Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health Italia SpA's earnings per share without non-recurring items for the
six
months ended in Jun. 2025 was €10.09.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2025 was €16.99.
During the past 12 months, Health Italia SpA's average earnings per share (NRI) Growth Rate was 1.40% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 6.50% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -30.10% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Health Italia SpA's EPS without NRI or its related term are showing as below:
MIL:HI'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -78.6 Med: 12.2 Max: 350.7
Current: 6.5
During the past 10 years, Health Italia SpA's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 350.70% per year. The lowest was -78.60% per year. And the median was 12.20% per year.
MIL:HI's 3-Year EPS without NRI Growth Rate is not ranked
in the Healthcare Plans industry.
Industry Median: 1.4
vs MIL:HI: 6.50
Health Italia SpA's EPS (Basic) for the
six
months ended in Jun. 2025 was €10.09.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 was €16.21.
Health Italia SpA (MIL:HI) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Health Italia SpA EPS without NRI Related Terms
Health Italia SpA EPS without NRI Historical Data
* Premium members only.
The historical data trend for Health Italia SpA's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:HI vs UNH, CVS, CI: EPS without NRI Comparison
For the Healthcare Plans subindustry, Health Italia SpA's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Italia SpA PE Ratio without NRI vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Health Italia SpA's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Health Italia SpA's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €16.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Italia SpA (MIL:HI) has a EPS without NRI of €16.99 as of Jun. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Health Italia SpA and its competitors.
Is Health Italia SpA's EPS without NRI too high?
Health Italia SpA's current EPS without NRI is €16.99. Overall, Health Italia SpA has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Health Italia SpA's EPS without NRI compare to UNH and CVS?
Health Italia SpA's EPS without NRI of €16.99 can be compared against companies in the Healthcare Plans industry. The industry median EPS without NRI is 1.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Plans company?
The median EPS without NRI among Healthcare Plans companies is 1.40, based on 17 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Health Italia SpA and its competitors. For the Healthcare Plans industry, the median EPS without NRI is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Italia SpA's current EPS without NRI is €16.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Italia SpA stock overvalued right now?
Health Italia SpA (MIL:HI) has a current EPS without NRI of €16.99. The stock's GF Value™ is €142.57, compared to a current price of €299.00 — trading 109.7% above its estimated fair value. The current EPS without NRI is €16.99. Health Italia SpA's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Health Italia SpA (MIL:HI), the current EPS without NRI is €16.99 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Italia SpA (MIL:HI) Overvalued in 2026?
Based on GuruFocus' analysis, Health Italia SpA stock appears to be overvalued.
The current stock price of €299.00 is trading 109.7% above its estimated GF Value™ of €142.57.
Key valuation signals for MIL:HI:
EPS without NRI: €16.99
GF Value™: €142.57 vs. price of €299.00 (109.7% above fair value)
No single metric tells the full story. See the MIL:HI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Italia SpA is an Italy based company engaged in offering integrated healthcare services. It operates in the promotion of integrated and alternative healthcare solutions and provides administrative, liquidation, information technology and consulting services for health funds, health care funds and mutual-aid companies. In addition, the group is also active in the corporate welfare market and manages outsourced flexible benefit welfare plans.
43GF Score
Get the complete analysis for MIL:HI
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:HI has been successfully added to your 
